Insider Buying: Andean Precious Metals Corp. (CVE:APM) Insider Buys 84,400 Shares of Stock

Andean Precious Metals Corp. (CVE:APM) insider 2176423 Ontario Ltd. bought 84,400 shares of the business’s stock in a transaction that occurred on Tuesday, October 8th. The shares were bought at an average cost of C$1.51 per share, for a total transaction of C$127,359.60.

2176423 Ontario Ltd. also recently made the following trade(s):

• On Wednesday, October 2nd, 2176423 Ontario Ltd. acquired 213,800 shares of Andean Precious Metals stock. The shares were bought at an average price of C$1.38 per share, for a total transaction of C$294,530.88.
• On Tuesday, September 24th, 2176423 Ontario Ltd. bought 700,000 shares of Andean Precious Metals stock. The stock was purchased at an average price of C$1.36 per share, with a total value of C$952,000.00.
• On Monday, September 16th, 2176423 Ontario Ltd. purchased 204,600 shares of Andean Precious Metals stock. The shares were purchased at an average cost of C$1.14 per share, for a total transaction of C$233,141.70.

Andean Precious Metals Trading Up 2.4 %

APM traded up C$0.04 during trading on Friday, hitting C$1.72. 20,030 shares of the company’s stock were exchanged, compared to its average volume of 164,525. Andean Precious Metals Corp. has a fifty-two week low of C$0.54 and a fifty-two week high of C$1.74. The company has a market cap of C$256.90 million, a PE ratio of 4.54 and a beta of 1.13. The firm’s 50 day moving average price is C$1.16.

Andean Precious Metals (CVE:APM) last posted its earnings results on Tuesday, August 13th. The company reported C$0.08 earnings per share for the quarter, hitting analysts’ consensus estimates of C$0.08. The company had revenue of C$95.47 million for the quarter. Andean Precious Metals had a net margin of 23.75% and a return on equity of 41.08%. As a group, research analysts expect that Andean Precious Metals Corp. will post 0.3792135 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, Desjardins boosted their price objective on Andean Precious Metals from C$1.60 to C$1.70 and gave the company a “buy” rating in a report on Tuesday, September 3rd.

Andean Precious Metals Company Profile

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.